National brain tumour research funding needs to increase to £35 million a year
World Cup challenge to give brain tumours the boot
As many of the world’s leading football players gather in Qatar, our own World Cup challenge kicks off today.
Supporters from all over the UK are practicing their fancy footwork by taking part in the One Million Keepy Uppy Challenge for Brain Tumour Research. They have pledged their keepy uppies towards our goal and are raising funds to help us show brain tumours the red card.
Amongst those backing the challenge is Ollie Leach (pictured, credit: MK Dons), who was facing a promising career as a professional sportsman before his dreams were crushed by a brain tumour diagnosis.
Ollie was an apprentice at MK Dons – the professional side which helped launch the challenge last week – when he began suffering from double vision during training in March 2020. He was diagnosed with a low-grade germinoma and had surgery to remove it, but was left with vision problems which ruined his future in football.
Now 21, Ollie is encouraging everyone to get involved, football fan or not. He said: “It sounds fun and I hope it raises lots of awareness and funds through sponsorship to allow the charity’s scientists to continue their vital work to help find a cure for brain tumours.”
He’s not the only player urging people to join our team. Former Liverpool FC star, José Enrique, shared our trailer with his social media followers, writing: “This is a great cause and really close to my heart, so get involved!”
There’s still time to join our team as the challenge runs until the final whistle is blown on Sunday 18th December. Get involved, earn your challenge medal and raise vital funds to help give brain tumours the boot. Join our team by clicking here.
- One Million Keepy Uppy Challenge for Brain Tumour Research
- Ollie’s story on BBC News Online
- MK Dons supports our footie challenge
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.